Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Infectious Diseases

• Publication date

  2008-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/593021PMID 19032070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

  2008cited by this paper
• Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain

  2008cited by this paper
• [Neutralizing antibodies in hepatitis C virus infection].

  2008cited by this paper
• Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

  2008cited by this paper
• Neutralizing antibodies in hepatitis C virus infection.

  2007cited by this paper
• New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus

  2007cited by this paper
• Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies

  2007cited by this paper
• Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity

  2007cited by this paper
• Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant

  2007cited by this paper
• Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

  2007cited by this paper
• Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

  2007cited by this paper
• Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus

  2006cited by this paper
• Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

  2006cited by this paper
• Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a

  2006cited by this paper
• Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I

  2006cited by this paper
• Structure of the catalytic domain of the hepatitis C virus NS2-3 protease

  2006cited by this paper
• Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus

  2006cited by this paper
• Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost

  2006cited by this paper
• Hepatitis C virus entry: Molecular biology and clinical implications

  2006cited by this paper
• Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

  2005cited by this paper
• An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

  2005cited by this paper
• Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

  2005cited by this paper
• Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

  2005cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• Robust hepatitis C virus infection in vitro.

  2005cited by this paper
• Complete Replication of Hepatitis C Virus in Cell Culture

  2005cited by this paper
• Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

  2005cited by this paper
• Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin.

  2004cited by this paper
• High Prevalence of Hepatitis C Virus Type 5 in Central France Evidenced by a Prospective Study from 1996 to 2002

  2004cited by this paper
• Inaugural Article: Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

  2002cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool.

  1998cited by this paper
• Genotyping of hepatitis C virus in South Africa

  1995cited by this paper
• Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

  1994cited by this paper
• At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

  1993cited by this paper
• Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.

  1993cited by this paper

• Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein

  2025cites this paper
• The Hepatitis C Virus Genotype 3a S310 Strain Permits Claudin‐1–Independent Entry

  2025cites this paper
• Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicity

  2025cites this paper
• Selection and characterization of a broadly neutralizing class of HCV anti-E2 VH1-69 antibodies

  2025cites this paper
• Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein

  2024cites this paper
• JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralization

  2024cites this paper
• Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412–425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles

  2023cites this paper
• ATAD1 inhibits hepatitis C virus infection by removing the viral TA‐protein NS5B from mitochondria

  2023cites this paper
• Mechanisms and Consequences of Genetic Variation in Hepatitis C Virus (HCV).

  2023cites this paper
• Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate

  2022cites this paper
• Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

  2022cites this paper
• Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice.

  2022cites this paper
• High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor

  2022cites this paper
• In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus

  2021cites this paper
• Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins.

  2021cites this paper
• Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors.

  2021cites this paper
• Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with hepatitis C virus envelope glycoproteins

  2021influential citation
• Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies

  2021cites this paper
• Camel milk is a neglected source of brucellosis among rural Arab communities

  2020cites this paper
• Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity

  2020cites this paper
• Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model

  2020cites this paper
• Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency

  2020cites this paper
• Zellkultursysteme als Basis der Therapieentwicklung für chronische Hepatitis C

  2020cites this paper
• Zellkultursysteme als Basis der Therapieentwicklung für chronische Hepatitis C

  2019cites this paper
• Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B cell-Based Vaccine Development.

  2019cites this paper
• The Hepatitis C Virus Replicon System and Its Role in Drug Development

  2019cites this paper
• Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

  2019cites this paper
• Current status and future development of infectious cell‐culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies

  2018cites this paper
• In Vitro Neutralization Assay Using Cultured Hepatitis C Virus.

  2018cites this paper
• High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals

  2018cites this paper
• Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry

  2018cites this paper
• Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry

  2018cites this paper
• Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms

  2018cites this paper
• Zellkultursysteme als Basis der Therapieentwicklung für chronische Hepatitis C

  2018cites this paper
• Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB

  2018cites this paper
• Hepatitis C virus: Morphogenesis, infection and therapy

  2018cites this paper
• Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).

  2018cites this paper
• Development of an Infectious Cell Culture System for Hepatitis C Virus Genotype 6a Clinical Isolate Using a Novel Strategy and Its Sensitivity to Direct-Acting Antivirals

  2018cites this paper
• Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies.

  2018cites this paper
• Long-term clinical, histological and virological outcomes after sustained virologic response in patients with chronic hepatitis C

  2017cites this paper
• Explorer Development of an Intergenotypic Hepatitis C Virus ( HCV ) Cell Culture Method To Assess Antiviral Susceptibilities and Resistance Development of HCV NS 3 Protease Genes from HCV Genotypes 1 to 6

  2017cites this paper
• Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions

  2017cites this paper
• Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A

  2017cites this paper
• A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner

  2017cites this paper
• Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors

  2017cites this paper
• Antimicrobial Agents and Chemotherapy AAC 00037-17 R 1 2 3 Efficient hepatitis C virus genotype 1 b Core-NS 5 A recombinants permit 4 efficacy testing of protease and NS 5 A inhibitors 5

  2017cites this paper
• The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.

  2016cites this paper
• Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection

  2016cites this paper
• Role of Nonstructural Proteins in HCV Replication

  2016cites this paper
• Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus

  2016cites this paper
• Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge

  2015cites this paper
• Long‐term follow‐up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure

  2015cites this paper
• Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant

  2015cites this paper
• The role of stromal cells in Hepatitis C virus infection

  2015cites this paper
• Hepatitis C virus infection of cholangiocarcinoma cell lines Short Title: HCV infects cholagiocarcinoma cells Article Type: Standard

  2015cites this paper
• Full Title: Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection Short Title: Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection

  2015cites this paper
• University of Birmingham Hepatitis C virus infection of cholangiocarcinoma cell lines

  2015cites this paper
• Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection

  2015cites this paper
• Hepatitis C virus infection of cholangiocarcinoma cell lines

  2015cites this paper
• Advances in experimental systems to study hepatitis C virus in vitro and in vivo.

  2015cites this paper
• University of Birmingham Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection

  2015cites this paper
• Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications

  2015cites this paper
• Determining the Involvement and Therapeutic Implications of Host Cellular Factors in Hepatitis C Virus Cell-to-Cell Spread

  2014cites this paper
• On the history of hepatitis C virus cell culture systems.

  2014cites this paper
• Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

  2014influential citation
• Unfolded protein response in hepatitis C virus infection

  2014influential citation
• Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

  2014cites this paper
• Factors associated with resolution and progression of HIV/hepatitis C virus infection.

  2014cites this paper
• Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.

  2014cites this paper
• Structural characterization of viral envelope glycoproteins

  2014cites this paper
• Effect of Differentially Expressed MicroRNAs 602 and 323-5p on Hepatitis C Virus Genotype 1b Viral Load in Infected Liver Cells

  2014cites this paper
• Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2

  2013cites this paper
• Entry and replication of recombinant hepatitis C viruses in cell culture.

  2013cites this paper
• Identification of Alpha Interferon-Induced Envelope Mutations of Hepatitis C Virus In Vitro Associated with Increased Viral Fitness and Interferon Resistance

  2013cites this paper
• Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization

  2013cites this paper
• Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

  2013cites this paper
• Chapter 2 Cell Culture Systems for Hepatitis C Virus

  2013cites this paper
• Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.

  2013cites this paper
• Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-Specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inhibitor

  2013cites this paper
• Thermo-stability of seven Hepatitis C virus genotypes in vitro and in vivo

  2013cites this paper
• Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

  2013cites this paper
• A Novel Strategy To Develop a Robust Infectious Hepatitis C Virus Cell Culture System Directly from a Clinical Isolate

  2013cites this paper
• Cell culture systems for hepatitis C virus.

  2013cites this paper
• Thermostability of seven hepatitis C virus genotypes in vitro and in vivo

  2013cites this paper
• Study of hepatitis C virus entry in genetically humanized mice.

  2013cites this paper
• Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells

  2013cites this paper
• Hepatitis C virus vaccines in the era of new direct-acting antivirals

  2013cites this paper
• Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates.

  2013cites this paper
• Major models of HCV infection

  2013cites this paper
• The Molecular Basis of Antibody Mediated Neutralization of Hepatitis C Virus

  2013cites this paper
• Fitness and Interferon Resistance Associated with Increased Viral Vitro In Envelope Mutations of Hepatitis C Virus Identification of Alpha Interferon-Induced

  2013cites this paper
• L'EGCG et la delphinidine : deux nouvelles molécules naturelles inhibant l'entrée du virus de l'hépatite C

  2012cites this paper
• Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system

  2012cites this paper
• Reverse Genetic Tools to Study Hepatitis C Virus

  2012cites this paper
• Investigating virus entry using cell-culture adapted hepatitis C virus

  2012cites this paper
• Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein

  2012cites this paper
• A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.

  2012cites this paper
• Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains

  2012cites this paper
• MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles

  2012cites this paper
• Analysis of Functional Differences between Hepatitis C Virus NS5A of Genotypes 1–7 in Infectious Cell Culture Systems

  2012cites this paper